Cluzeau, T., Guolo, F., Chiche, E., Minetto, P., Rahme, R., Bertoli, S., . . . Lemoli, R. M. Long-term real-world evidence of CPX-351 of high-risk patients with AML identified high rate of negative MRD and prolonged OS. Elsevier.
Chicago Style (17th ed.) CitationCluzeau, Thomas, et al. Long-term Real-world Evidence of CPX-351 of High-risk Patients with AML Identified High Rate of Negative MRD and Prolonged OS. Elsevier.
MLA (9th ed.) CitationCluzeau, Thomas, et al. Long-term Real-world Evidence of CPX-351 of High-risk Patients with AML Identified High Rate of Negative MRD and Prolonged OS. Elsevier.
Warning: These citations may not always be 100% accurate.